Cornerstone Financial Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,741
Closed -$324K 131
2017
Q3
$324K Buy
1,741
+397
+30% +$70.3K 0.12% 93
2017
Q2
$232K Buy
+1,344
New +$219K 0.09% 111
2017
Q1
Sell
-4,706
Closed -$690K 143
2016
Q4
$690K Sell
4,706
-491
-9% -$73.9K 0.22% 84
2016
Q3
$867K Sell
5,197
-4,388
-46% -$742K 0.3% 64
2016
Q2
$1.46M Buy
9,585
+193
+2% +$30K 0.52% 50
2016
Q1
$1.41M Buy
9,392
+502
+6% +$74.6K 0.55% 59
2015
Q4
$1.44M Buy
+8,890
New +$1.4M 0.53% 51

Other funds holding AMGN

Cornerstone Financial Partners's AMGN Position: Q4 2017 in Review

Cornerstone Financial Partners sold out of Amgen (AMGN) in Q4 2017, closing a stake of 1,741 shares — an estimated $324K sold.

Cornerstone Financial Partners first reported a position in AMGN in Q4 2015 and held it in 7 quarters. The position peaked at $1.46M in Q2 2016. 1,735 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

  • Cornerstone Financial Partners reported no remaining Amgen position as of Q4 2017 after selling out during the quarter.
  • Cornerstone Financial Partners sold 1,741 Amgen shares in Q4 2017, an estimated $324K.
  • Cornerstone Financial Partners first reported a position in Amgen in Q4 2015 and held it in 7 quarters.
  • Cornerstone Financial Partners's Amgen position peaked at $1.46M in Q2 2016.
  • 1,735 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on Cornerstone Financial Partners's 13F filing for Q4 2017, filed 22 Jan 2018.